(Q39961876)

15 September 2017

title

The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization (English)

1 reference

15 September 2017

0 references

1 reference

Burak Turgut

1

1 reference

15 September 2017

Mete Guler

2

1 reference

15 September 2017

Nusret Akpolat

3

1 reference

15 September 2017

Tamer Demır

4

1 reference

15 September 2017

Ulku Celıker

5

1 reference

15 September 2017

language of work or name

1 reference

7 December 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

36

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

34-40

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Ocular angiogenesis: the role of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibition of histamine release and cytokine production by mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibits prostaglandin E2 production from synovial cells by suppressing peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunophilin-ligands FK506 and CsA inhibit HIF1alpha expression by a VHL- and ubiquitin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Angiogenesis and surgery: from mice to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inflammation as a tumor promoter in cancer induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Angiogenesis and chronic inflammation: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

10.3109/02713683.2010.516620

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference